Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments. For more information, visit Cresilon.com.
--
DISCLAIMER: The products and the claims made about specific products on or through this site have not been evaluated by the United States Food and Drug Administration (FDA) and are not approved to diagnose, treat, cure, or prevent disease. This notice will be updated upon FDA approval.
--
DISCLAIMER: The products and the claims made about specific products on or through this site have not been evaluated by the United States Food and Drug Administration (FDA) and are not approved to diagnose, treat, cure, or prevent disease. This notice will be updated upon FDA approval.
Location: United States, New York
Employees: 11-50
Phone: +1 347-435-2226
Total raised: $77M
Founded date: 2010
Investors 6
| Date | Name | Website |
| - | Hammerston... | hammerston... |
| - | Innovating... | innovating... |
| - | Dorm Room ... | dormroomfu... |
| - | FirstXFoun... | firstxfoun... |
| 09.05.2025 | Catalio Ca... | cataliocap... |
| - | Future Lab... | futurelabs... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.11.2022 | Series A | $77M | - |
Mentions in press and media 9
| Date | Title | Description |
| 16.08.2024 | Cresilon's TRAUMAGEL: A Game-Changer in Emergency Medicine | In the world of emergency medicine, seconds can mean the difference between life and death. Cresilon Inc., a Brooklyn-based biotechnology company, has taken a monumental step forward with the FDA clearance of TRAUMAGEL, a revolutionary hemo... |
| 15.08.2024 | Cresilon Receives FDA Clearance for TRAUMAGEL | Hemostatic gel designed to control moderate to severe bleeding in seconds and save lives NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical devi... |
| 15.08.2024 | Cresilon Receives FDA Clearance for TRAUMAGEL | Hemostatic gel designed to control moderate to severe bleeding in seconds and save lives NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical devi... |
| 09.07.2024 | Cresilon's Revolutionary Hemostatic Gel Technology Shows Promising Results for Treatment of Penetrating Traumatic Brain Injury in Study Performed with Walter Reed Army Institute of Research | Findings from preclinical study demonstrate potential for a field and prehospital treatment following a penetrating TBI NEW YORK, July 9, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focu... |
| 20.05.2024 | Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus | Revolutionary hemostatic gel for veterinary surgeons available in U.K. and across Europe through Veterinary Instrumentation and distribution partners NEW YORK, May 20, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-ba... |
| 24.04.2024 | VETIGEL Now Available Through All Major U.S. Distributors of Veterinary Products and Services | Cresilon expands nationwide reach for VETIGEL through distribution agreements with Midwest Veterinary Supply, Victor Medical Company, and Penn Veterinary Supply NEW YORK, April 24, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), ... |
| 01.11.2022 | Cresilon’s $25M Fundraise Could Help its Hemostatic Gel Hit the Human Health Market | The last time a college student founded a healthcare startup promising to do something revolutionary with blood, it ended up being quite messy. Hopefully things go better for Cresilon. The Brooklyn-based startup, which manufactures a gel to... |
| 31.10.2022 | Cresilon Raises $25M in Series A-4 Financing | Cresilon, a New York-based biotechnology company providing a safe solution to stop bleeding, raised $25M in Series A-4 funding. The round was led by Paulson Investment Company. The company intends to use the funds to accelerate its global g... |
| - | Cresilon, Inc. | “Our plant-based technology stops traumatic and surgical bleeds in seconds without the need for manual pressure. Stop bleeding in seconds.” |